[Federal Register Volume 67, Number 35 (Thursday, February 21, 2002)]
[Notices]
[Page 8011]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-4180]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Concerning Hantavirus Vaccine

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent No. 5,614,193 entitled 
``Hantavirus Vaccine'' issued March 25, 1997. The United States 
government as represented by the Secretary of the Amy has rights in 
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664. Both 
at telefax (301) 61-5034.

SUPPLEMENTARY INFORMATION: Vaccine formulations for inducing protective 
immune response to Hantaviruses in humans are disclosed. These 
formulations include an attenuated vaccine virus vector containing 
cDNA's encoding Hantavirus nucleocapsid N protein, G1 and G2 
glycoproteins. Methods for the use of these formulations also are 
disclosed.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-4180 Filed 2-20-02; 8:45 am]
BILLING CODE 3710-08-M